Works matching AU Umeda, M.

Results: 57
    1

    Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?

    Published in:
    2023
    By:
    • Hasegawa, T.;
    • Kawakita, A.;
    • Ueda, N.;
    • Funahara, R.;
    • Tachibana, A.;
    • Kobayashi, M.;
    • Kondou, E.;
    • Takeda, D.;
    • Kojima, Y.;
    • Sato, S.;
    • Yanamoto, S.;
    • Komatsubara, H.;
    • Umeda, M.;
    • Kirita, T.;
    • Kurita, H.;
    • Shibuya, Y.;
    • Komori, T.
    Publication type:
    Correction Notice
    2

    Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study.

    Published in:
    Osteoporosis International, 2019, v. 30, n. 1, p. 231, doi. 10.1007/s00198-018-4746-8
    By:
    • Japanese Study Group of Co-operative Dentistry with Medicine (JCDM);
    • Hasegawa, T.;
    • Komori, T.;
    • Iwata, E.;
    • Kobayashi, M.;
    • Hayashida, S.;
    • Soutome, S.;
    • Umeda, M.;
    • Kondo, E.;
    • Yamada, SI.;
    • Kurita, H.;
    • Takeda, Y.;
    • Tojyo, I.;
    • Fujita, S.;
    • Miyamoto, H.;
    • Shibuya, Y.;
    • Kawaoka, Y.;
    • Kojima, Y.;
    • Ueda, N.;
    • Kirita, T.
    Publication type:
    Article
    3

    A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?

    Published in:
    Osteoporosis International, 2017, v. 28, n. 8, p. 2465, doi. 10.1007/s00198-017-4063-7
    By:
    • Hasegawa, T.;
    • Kawakita, A.;
    • Ueda, N.;
    • Funahara, R.;
    • Tachibana, A.;
    • Kobayashi, M.;
    • Kondou, E.;
    • Takeda, D.;
    • Kojima, Y.;
    • Sato, S.;
    • Yanamoto, S.;
    • Komatsubara, H.;
    • Umeda, M.;
    • Kirita, T.;
    • Kurita, H.;
    • Shibuya, Y.;
    • Komori, T.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    IL‐15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis.

    Published in:
    Journal of Internal Medicine, 2021, v. 289, n. 2, p. 206, doi. 10.1111/joim.13154
    By:
    • Shimizu, T.;
    • Koga, T.;
    • Furukawa, K.;
    • Horai, Y.;
    • Fujikawa, K.;
    • Okada, A.;
    • Okamoto, M.;
    • Endo, Y.;
    • Tsuji, S.;
    • Takatani, A.;
    • Umeda, M.;
    • Fukui, S.;
    • Sumiyoshi, R.;
    • Kawashiri, S.‐y.;
    • Iwamoto, N.;
    • Igawa, T.;
    • Ichinose, K.;
    • Tamai, M.;
    • Sakamoto, N.;
    • Nakamura, H.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50